Guo R - Search Results

1

The Role of FGFR1 Gene Amplification as a Poor Prognostic Factor in Squamous Cell Lung Cancer: A Meta-Analysis of Published Data.

Wang Y, Gao W, Xu J, Chen X, Yang Y, Zhu Y, Yin Y, Guo R, Liu P, Shu Y, Liu L. Wang Y, et al. Among authors: guo r. Biomed Res Int. 2015;2015:763080. doi: 10.1155/2015/763080. Epub 2015 Dec 16. Biomed Res Int. 2015. PMID: 26788508 Free PMC article.

2

Tamoxifen inhibits proliferation and induces apoptosis in human hepatocellular carcinoma cell line HepG2 via down-regulation of survivin expression.

Guo R, Huang Z, Shu Y, Jin S, Ge H. Guo R, et al. Biomed Pharmacother. 2009 Jun;63(5):375-9. doi: 10.1016/j.biopha.2008.09.010. Epub 2008 Oct 23. Biomed Pharmacother. 2009. PMID: 18993026

3

[Insulin/PI3K signalling pathway regulates the expression of survivin in liver cancer HepG2 cells].

Guo RH, Jin SD, Cai J, Huang ZH, Shu YQ. Guo RH, et al. Zhonghua Zhong Liu Za Zhi. 2008 Oct;30(10):745-8. Zhonghua Zhong Liu Za Zhi. 2008. PMID: 19173802 Chinese.

4

Involvement of mTOR and survivin inhibition in tamoxifen-induced apoptosis in human hepatoblastoma cell line HepG2.

Guo R, Wang T, Shen H, Ge HM, Sun J, Huang ZH, Shu YQ. Guo R, et al. Biomed Pharmacother. 2010 Apr;64(4):249-53. doi: 10.1016/j.biopha.2009.06.007. Epub 2009 Oct 22. Biomed Pharmacother. 2010. PMID: 19931998

5

The effect of endostatin and gemcitabine combined with HIFU on the animal xenograft model of human pancreatic cancer.

Wang RS, Liu LX, Gu YH, Lin QF, Guo RH, Shu YQ. Wang RS, et al. Biomed Pharmacother. 2010 May;64(5):309-12. doi: 10.1016/j.biopha.2009.09.011. Epub 2009 Nov 5. Biomed Pharmacother. 2010. PMID: 19942398

6

Expression profile of multiple aquaporins in human gastric carcinoma and its clinical significance.

Shen L, Zhu Z, Huang Y, Shu Y, Sun M, Xu H, Zhang G, Guo R, Wei W, Wu W. Shen L, et al. Among authors: guo r. Biomed Pharmacother. 2010 May;64(5):313-8. doi: 10.1016/j.biopha.2009.12.003. Epub 2010 Jan 8. Biomed Pharmacother. 2010. PMID: 20106632

7

[Clinical Study of Erlotinib in the Treatment of Patients with Advanced Stage Non-small Cell Lung Cancer.].

Wang T, Sun J, Gao W, Shen H, Li X, Yin Y, Shu Y, Guo R. Wang T, et al. Among authors: guo r. Zhongguo Fei Ai Za Zhi. 2009 Dec 20;12(12):1287-90. doi: 10.3779/j.issn.1009-3419.2009.12.12. Zhongguo Fei Ai Za Zhi. 2009. PMID: 20723385 Free article. Chinese.

8

[Down-regulation of mTOR activity and survivin expression during tamoxifen-induced apoptosis in hepatoblastoma cells].

Guo RH, Wang TS, Chen XF, Huang ZH, Shu YQ. Guo RH, et al. Zhonghua Zhong Liu Za Zhi. 2010 Dec;32(12):903-6. Zhonghua Zhong Liu Za Zhi. 2010. PMID: 21223797 Chinese.

9

Subsequent chemotherapy reverses acquired tyrosine kinase inhibitor resistance and restores response to tyrosine kinase inhibitor in advanced non-small-cell lung cancer.

Guo R, Chen X, Wang T, Zhang Z, Sun J, Shu Y. Guo R, et al. BMC Cancer. 2011 Mar 2;11:90. doi: 10.1186/1471-2407-11-90. BMC Cancer. 2011. PMID: 21366910 Free PMC article.

10

Phase II study of weekly irinotecan plus cisplatin in patients with previously untreated extensive-stage extrapulmonary small cell carcinoma.

Jin S, Wang T, Chen X, Xu B, Sun J, Guo R, Shu Y. Jin S, et al. Among authors: guo r. Onkologie. 2011;34(7):378-81. doi: 10.1159/000329609. Epub 2011 Jun 24. Onkologie. 2011. PMID: 21734424 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,923 results

Search Page

Filters